Recall: Albuterol Sulfate
Jul. 2023Pharmacy Updates
Cipla US is recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation), manufactured in November 2021. They initiated the recall because of a complaint where leakage was observed through the inhaler’s inhaler valve. This drug is used to treat asthma and to prevent exercise-induced asthma. Read the full text of the Albuterol Sulfate recall.
Recent Announcements
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Sep. 2026Education/Webinars
Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)
Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).Sep. 2026Pharmacy Updates
Voluntary nationwide recall: Dextrose (Baxter – August 2026)
Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.Sep. 2026Pharmacy Updates